skip to main content

    Updated Visitor Guidelines

 

MENU

 

Sarcoma

U-M to lead multi-site $12M grant to study rare type of sarcoma

An international team of researchers led by the University of Michigan Rogel Cancer Center received a collaborative grant from the National Cancer Institute with a goal of bringing new insights into leiomyosarcoma, a rare form of cancer that seemingly originates in smooth muscle. The grant, worth $12.3 million, is through the NCI’s SPORE, or Specialized Program of Research Excellence, which funds collaborative, interdisciplinary translational cancer research.

Despite bone cancer and COVID, Kara Wolter kept swimming

Swimming was how Kara Wolter found solace, especially after her bone cancer diagnosis and leg amputation. But COVID often took away her safe place and delayed her Swim Across America race. Here’s how she ultimately crossed the finish line.

Getting Through Stage 3 Sarcoma

Nearly two years after being treated at the University of Michigan Rogel Cancer Center, Gerald Dixon has an active life that includes selling houses, jogging and plying the local rivers and lakes in his 27-foot cabin cruiser.

Shared Science Saves Lives

When Ron Diehl was diagnosed in 1999 with Ewing sarcoma, a rare cancer that mainly affects children and young adults, he wanted to speak to someone who survived the disease as a way to maintain hope that he could get better. A young man of 34, he had a wife and three young kids, as well as a family dairy farm to run in the small town of Lupton, Mich.

When Cancer Comes Back

Jennifer Kelley was unprepared for the rare diagnosis of leiomyosarcoma at age 52, especially since it was her third experience with cancer in a mere 30 months. She had the cancerous lump under her arm surgically removed and followed up with five cycles of chemotherapy as a precaution. Because Kelley's cancer had spread into a lymph node, he explained the cancer was categorized as stage 4 and expected to return.

Pages